1. Home
  2. FLNC vs EVO Comparison

FLNC vs EVO Comparison

Compare FLNC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluence Energy Inc.

FLNC

Fluence Energy Inc.

HOLD

Current Price

$15.09

Market Cap

2.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.50

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNC
EVO
Founded
2018
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
821.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FLNC
EVO
Price
$15.09
$2.50
Analyst Decision
Hold
Strong Buy
Analyst Count
18
1
Target Price
$16.93
$7.00
AVG Volume (30 Days)
3.6M
110.1K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,262,830,000.00
N/A
Revenue This Year
$51.18
N/A
Revenue Next Year
$21.37
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.46
$2.31
52 Week High
$33.51
$4.80

Technical Indicators

Market Signals
Indicator
FLNC
EVO
Relative Strength Index (RSI) 39.36 36.10
Support Level $13.92 $2.31
Resistance Level $18.21 $3.78
Average True Range (ATR) 0.95 0.08
MACD 0.20 0.01
Stochastic Oscillator 3.67 22.51

Price Performance

Historical Comparison
FLNC
EVO

About FLNC Fluence Energy Inc.

Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: